Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1574: 113-9, 2014 Jul 29.
Article in English | MEDLINE | ID: mdl-24924804

ABSTRACT

The midbrain dopaminergic perikarya are differentially affected in Parkinson׳s disease (PD). This study compared the effects of a partial unilateral intrastriatal 6-hydroxydopamine (6-OHDA) lesion model of PD on the number, morphology, and nucleolar volume of dopaminergic cells in the substantia nigra pars compacta (SNpc), ventral tegmental area (VTA), and retrorubral field (RRF). Adult, male rats (n=10) underwent unilateral intrastriatal infusion of 6-OHDA (12.5µg). Lesions were verified by amphetamine-stimulated rotation 7 days post-infusion. Rats were euthanized 14 days after treatment with 6-OHDA and brains were stained with a tyrosine hydroxylase-silver nucleolar (TH-AgNOR) stain. Dopaminergic cell number and morphology in the lesioned and intact hemispheres were quantified using stereological methods. The magnitude of decrease in planimetric volume, neuronal number, cell density, and neuronal volume resulting from 6-OHDA lesion differed between regions, with the SNpc exhibiting the greatest loss of neurons (46%), but the smallest decrease in neuronal volume (13%). The lesion also resulted in a decrease in nucleolar volume that was similar in all three regions (22-26%). These findings indicate that intrastriatal 6-OHDA lesion differentially affects dopaminergic neurons in the SNpc, VTA, and RRF; however, the resulting changes in nucleolar morphology suggest a similar cellular response to the toxin in all three cell populations.


Subject(s)
Dopaminergic Neurons/pathology , Mesencephalon/drug effects , Mesencephalon/pathology , Oxidopamine/toxicity , Parkinsonian Disorders/pathology , Amphetamine/pharmacology , Animals , Cell Count , Cell Nucleolus/drug effects , Cell Nucleolus/pathology , Cell Nucleolus/physiology , Cell Shape , Cell Size , Central Nervous System Stimulants/pharmacology , Functional Laterality , Male , Mesencephalon/physiopathology , Motor Activity/drug effects , Parkinsonian Disorders/physiopathology , Pars Compacta/drug effects , Pars Compacta/pathology , Pars Compacta/physiopathology , Rats , Silver Compounds , Tyrosine 3-Monooxygenase , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/pathology , Ventral Tegmental Area/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...